CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy (vol 139, pg 95, 2013)

被引：0
|
作者：
Teft, Wendy A. [1 ]
Gong, Inna Y. [1 ,2 ]
Dingle, Brian [3 ]
Potvin, Kylea [3 ]
Younus, Jawaid [3 ]
Vandenberg, Theodore A. [3 ]
Brackstone, Muriel [3 ,4 ]
Perera, Francisco E. [3 ]
Choi, Yun-Hee [5 ]
Zou, Guangyong [5 ]
Legan, Robin M. [1 ]
Tirona, Rommel G. [1 ,2 ]
Kim, Richard B. [1 ,2 ,3 ,6 ]
机构：
[1] Univ Western Ontario, Dept Med, Div Clin Pharmacol, London, ON, Canada
[2] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada
[3] Univ Western Ontario, Dept Oncol, London, ON, Canada
[4] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada
[5] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada
[6] LHSC Univ Hosp, Dept Med, London, ON N6A 5A5, Canada
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2013年 / 142卷 / 01期
关键词：
D O I：
10.1007/s10549-013-2706-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [31] Probabilistic prediction of the human CYP3A4 and CYP2D6 metabolism sites in a molecule
    Dapkunas, Justas
    Sazonovas, Andrius
    Japertas, Pranas
    TOXICOLOGY LETTERS, 2008, 180 : S94 - S94
  • [32] Genetic variability of CYP2D6, CYP3A4 and CYP3A5 among the Egyptian population
    Mutawi, Thuraya M.
    Zedan, Mohamed M.
    Yahya, Raida S.
    Zakria, Mahmoud M.
    El-Sawi, Mamdouh R.
    Gaedigk, Andrea
    PHARMACOGENOMICS, 2021, 22 (06) : 323 - 334
  • [33] Sugar-mediated lyoprotection of purified human CYP3A4 and CYP2D6
    Chefson, Amandine
    Zhao, Jin
    Auclair, Karine
    JOURNAL OF BIOTECHNOLOGY, 2007, 130 (04) : 436 - 440
  • [34] Comparison of metasite and stardrop prediction of CYP3A4, CYP2C9 and CYP2D6
    Gopaul, V. Sashi
    Shin, Young
    Le, Hoa
    Baumgardner, Matthew
    Hop, Cornelis
    Khojasteh, Cyrus
    DRUG METABOLISM REVIEWS, 2009, 41 : 119 - 119
  • [35] SIMPLIFIED CYP2D6 METABOLIZER PHENOTYPE CATEGORIZATION OF PATIENTS TREATED WITH TAMOXIFEN: ROLE FOR ENDOXIFEN LEVEL MONITORING?
    Lee, C. L.
    Low, A. S. K.
    Fox, P.
    Balakrishnar, B.
    Balleine, R. L.
    Gao, B.
    Provan, P.
    Coulter, S.
    Liddle, C.
    Hui, R.
    Wilcken, N.
    Wong, M.
    Gurney, H.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 59 - 59
  • [36] Simplified CYP2D6 metabolizer phenotype categorization of patients treated with tamoxifen: Role for endoxifen level monitoring?
    Lee, Clara Inkyung
    Low, Amanda Siew Kee
    Fox, Peter
    Balakrishnar, Bavanthi
    Balleine, Rosemary L.
    Gao, Bo
    Provan, Pamela
    Coulter, Sally
    Liddle, Christopher
    Hui, Rina
    Wilcken, Nicholas
    Wong, Mark
    Gurney, Howard
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] CYP2D6*3, *4, *6 GENOTYPES AND ENDOMETRIAL THICKNESS IN PATIENTS WITH BREAST CANCER DURING TAMOXIFEN THERAPY
    Goryainova, A. Yu
    Usman, N. Yu
    Rubanovich, A., V
    Borinskaya, S. A.
    Meshcheryakov, A. A.
    BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2023, (05): : 18 - 25
  • [38] CYP2D6, CYP3A5, and CYP3A4 gene polymorphisms in Russian, Tatar, and Bashkir populations
    O. E. Mustafina
    I. A. Tuktarova
    D. D. Karimov
    R. Sh. Somova
    T. R. Nasibullin
    Russian Journal of Genetics, 2015, 51 : 98 - 107
  • [39] CYP2D6, CYP3A5, and CYP3A4 Gene Polymorphisms in Russian, Tatar, and Bashkir Populations
    Mustafina, O. E.
    Tuktarova, I. A.
    Karimov, D. D.
    Somova, R. Sh.
    Nasibullin, T. R.
    RUSSIAN JOURNAL OF GENETICS, 2015, 51 (01) : 98 - 107
  • [40] Influence of CYP2D6, CYP3A4 and CYP3A5 genotypes on the pharmacokinetics of bropmeridol and extrapyramidal symptoms
    Lee, SY
    Kim, YG
    Kim, HG
    Kim, JW
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 232 - 232
12345